Home / mesothelioma News / New drug hope for asbestos mesothelioma

New drug hope for asbestos mesothelioma

A new drug is showing promise as a treatment for mesothelioma — one of the most lethal cancers of all.

The drug, known as HRX9, works by preventing the cancer cells from avoiding apoptosis — the natural process by which unhealthy and damaged cells close themselves down and die.

“Both the immune system and nearby healthy cells send signals instructing damaged and unhealthy cells to undergo apoptosis, which is like programmed ‘cell suicide’. But cancer cells have developed a wide range of strategies to ignore these instructions,” says Professor Richard Morgan, from the University of Bradford’s Institute of Cancer Therapeutics, who developed the drug and who led the research.

“There’s a range of drugs which try to force apoptosis in different cancers, but this is the first one to work in mesothelioma.”

Mesothelioma is a cancer of the lining of the lung. It’s almost invariably caused by exposure to asbestos and is resistant to all current chemotherapies. Its prognosis is dismal, with those diagnosed usually given a year to live at most.

A study by the universities of Bradford and Surrey found that after three weeks’ treatment with HXR9, human mesothelioma tumours in mice stopped growing, with a complete loss of tumour blood vessels and widespread cancer cell death. The results are published in BMC Cancer journal.

HXR9 targets the HOX gene family, which includes 39 fairly similar genes that help enable the remarkably rapid cell division in growing embryos. Many of these genes are usually switched off in adults, but previous research has shown that in many cancers — including prostate, ovarian, and brain cancer, melanoma, and leukemia — HOX genes are switched back on, helping the cancer cells to proliferate and survive.

“We’ve effectively knocked out a key defence mechanism in this cancer through targeting the HOX genes,” says Professor Morgan.

A further key finding reported in the study, funded by the British Lung Foundation, was that mesothelioma has a very strong association with one of the HOX genes in particular — known as HOXB4.

“We examined the amount of HOXB4 protein in tumours of 21 mesothelioma patients and compared it with their length of survival. There was a clear link: the more HOXB4 we found, the shorter time the patient survived, so we may also have found a way to predict which patients have the most aggressive form of this cancer,” says Professor Morgan.

Because of greater awareness of the danger of asbestos in the West, the future incidence of mesothelioma is expected to decline. However, in Africa and some parts of Asia, asbestos is still commonly used in industries such as construction and ship building, and few precautions are taken when demolishing buildings that contain asbestos.

“Mesothelioma may become much less of a problem in the West, but it’s still going to be a significant public health problem in many parts of the world. We already know that it’s resistant to available drugs, which is why we need entirely new treatments,” says Professor Morgan.

Ian Jarrold, Head of Research at British Lung Foundation said: “Although still early days, this study is a significant step forward in that it is the first time a drug has been observed causing so-called ‘cell suicide’ in mesothelioma.

“People living with mesothelioma often tell us that among their first reactions to diagnosis is despair at the lack of treatment available. We hope that the progress being made in research we fund will soon provide new treatments and new hope for patients.”

 

Apply Also for the US Embassy Scholarship awards for int'l Students

About cazzy4u

Check Also

Class Action Lawsuits over Mesothelioma cases

Class Action Lawsuits over Mesothelioma cases A class action is a lawsuit filed by claimants …

9 comments

  1. I virtually never ever responses on weblogs, but i like you to know, that I constantly take pleasure in to arrive here. I hope you will keep up the excellent work. i am positive you inspire a whole lot of men and women, preventing mesothelioma, and maybe even a mesothelioma lawsuits

  2. I almost never responses on weblogs, but i like you to know, that I usually take pleasure in to come listed here. I hope you will maintain up the great function. i am positive you encourage a great deal of men and women, battling mesothelioma, and perhaps even a mesothelioma lawsuits

  3. I virtually in no way comments on weblogs, but i like you to know, that I constantly appreciate to occur listed here. I hope you will preserve up the good work. i am sure you inspire a whole lot of people, fighting mesothelioma, and possibly even a mesothelioma lawsuits

  4. I almost by no means responses on blogs, but i like you to know, that I always enjoy to come listed here. I hope you will maintain up the good work. i am confident you inspire a good deal of folks, combating mesothelioma, and possibly even a mesothelioma lawsuits

  5. I nearly in no way responses on blogs, but i like you to know, that I always enjoy to appear right here. I hope you will maintain up the good work. i am positive you encourage a great deal of individuals, combating mesothelioma, and maybe even a mesothelioma lawsuits

  6. I nearly never feedback on weblogs, but i like you to know, that I often enjoy to occur listed here. I hope you will hold up the good work. i am certain you encourage a great deal of men and women, battling mesothelioma, and possibly even a mesothelioma lawsuits

  7. I virtually in no way remark on weblogs, but I have to say, I take pleasure in studying about this tropic. Hope you will hold up the very good perform. I will for positive be again yet again

  8. Wow, this was awesome. Keep writing this kind of posts, you will get a lot of people to this page if you continue doing this. I will be visiting this page more often. thumbs up

  9. Wow, this was usefull. Keep writing this kind of stories, you will get a lot of people to this text if you continue working on this. I will be visiting this page more often. thx

Leave a Reply

Your email address will not be published. Required fields are marked *

error: Oooops!!! Content is protected !!!